EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma

Yu Zhang, Chen Chen, Tianhang Zhu, Wei Luo iD, Ranran Zhou, Wanlong Tan iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0334104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Program of Guangzhou, Shenzhen Third People’s Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoids play a pivotal role in tumorigenesis and cancer progression. However, the prognostic significance of glucocorticoid signaling-related genes remains poorly understood, particularly in kidney renal clear cell carcinoma (KIRC). Collected samples indicated KIRC patients exhibited elevated serum glucocorticoid levels compared to healthy donors ( P < 0.05). Glucocorticoid signaling-related genes were curated from the MSigDB database. The TCGA-KIRC cohort was utilized for training, while 7 independent public KIRC cohorts and local samples were employed for validation. Through LASSO and random forest analyses, ACADM, ANGPTL4, and NFKB2 were identified and subsequently incorporated into a multivariate Cox regression model. This gene signature emerged as a robust prognostic indicator across multiple cohorts (pooled hazard ratio [HR] = 2.73, 95% confidence interval [CI] = 2.05–3.65). In local samples, KIRC tissues exhibited increased infiltration of NFKB2+ cells and decreased levels of ACADM+ and ANGPTL4+ cells (all P < 0.05). Meta-analyses and spatial transcriptomics revealed a positive association between the signature and CD8+ T cell infiltration. Furthermore, the signature was associated with T cell exhaustion levels and could predict immunotherapeutic responses in both computational simulations and real-world clinical settings (all P < 0.05). In vivo experiments showed that NFKB2 knockdown inhibited tumor growth and the expansion of CD8+PDCD1+ T cells, effects that were reversible with corticosterone treatment (all P < 0.05). Collectively, a glucocorticoid signaling-related gene signature was developed and rigorously validated as a predictive tool for prognosis and immunotherapeutic response in KIRC, offering valuable insights for guiding personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsGlucocorticoidsHumansPrognosisSignal TransductionAnimalsMiceGene Expression Regulation, NeoplasticImmunotherapyFemaleMaleCell Line, TumorTranscriptomeAngiopoietin-Like Protein 4Gene Expression Profiling

Substanzen

GlucocorticoidsAngiopoietin-Like Protein 4

Autor:innen und Institutionen

  • Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Urology, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
  • Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Wei Luo, Wanlong Tan

Förderung

  • The Science and Technology Program of Guangzhou
  • Shenzhen Third People’s Hospital Research Fund

Zitieren

APA

Zhang, Y., Chen, C., Zhu, T., Luo, W., Zhou, R., & Tan, W. (2025). Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0334104

Vancouver

Zhang Y, Chen C, Zhu T, Luo W, Zhou R, Tan W. Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma. PLOS One. 2025. doi:10.1371/journal.pone.0334104

BibTeX
@article{Zhang2025,
  author = {Zhang, Yu and Chen, Chen and Zhu, Tianhang and Luo, Wei and Zhou, Ranran and Tan, Wanlong},
  title = {Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334104}
}
Kostenlos starten →